Frontiers in Hematology

Original Research

Published on 20 Jun 2024

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

in Blood Cancer

Vittorio Del Fabro
Uros Markovic
Sara Frazzetto
Roberta Sciortino
Claudia Bellofiore
Mary Ann Di Giorgio
Valerio Leotta
Anna Bulla
Angelo Curto Pelle
Federica Elia

Frontiers in Hematology

doi 10.3389/frhem.2024.1425677

567 views

Brief Research Report

Published on 17 Jun 2024

Novel cryopreservation medium for enhanced stability of T cells at −80°C

in Immunobiology and Immunotherapy

WenXuan Zhou
Chen Wang
Yao Shi
Yi Pan
XiaDuo Meng
XunLei Kang
Xu Han

Frontiers in Hematology

doi 10.3389/frhem.2024.1346627

1,408 views
2 citations

Brief Research Report

Published on 13 Jun 2024

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

in Blood Cancer

Theo Leitner
Cyrus Khandanpour
Knut Wendelin
Fuat Oduncu
Christoph Kimmich
Ralph Naumann
Miriam Kull
Hartmut Goldschmidt
Martin Ehmer
Claudia Kiewitz

Frontiers in Hematology

doi 10.3389/frhem.2024.1335161

699 views

Mini Review

Published on 28 May 2024

Exploring extramedullary hematopoiesis: unraveling the hematopoietic microenvironments

in Hematopoiesis and Stem Cells

Guadalupe Rivera-Torruco
Marcus O. Muench
Ricardo Valle-Rios

Frontiers in Hematology

doi 10.3389/frhem.2024.1371823

2,540 views
1 citation

Original Research

Published on 10 May 2024

Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis

in Red Cells, Iron and Erythropoiesis

Friederike Poppenborg
Alexander Röth
Raina Yamamoto
Hans Christian Reinhardt
Ferras Alashkar

Frontiers in Hematology

doi 10.3389/frhem.2024.1374181

1,176 views
2 citations

Review

Published on 08 May 2024

AL amyloidosis: an overview on diagnosis, staging system, and treatment

in Blood Cancer

Sonia Morè
Valentina Maria Manieri
Laura Corvatta
Erika Morsia
Antonella Poloni
Massimo Offidani

Frontiers in Hematology

doi 10.3389/frhem.2024.1378451

1,883 views
1 citation

Brief Research Report

Published on 26 Apr 2024

Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma

in Hematopoiesis and Stem Cells

Flavia Bigi
Paola Tacchetti
Alessandro Giorgi
Gaia Mazzocchetti
Vincenza Solli
Simona Barbato
Barbara Sinigaglia
Elena Campanini
Emanuele Favero
Marco Talarico

Frontiers in Hematology

doi 10.3389/frhem.2024.1386973

666 views
2 citations

Original Research

Published on 18 Apr 2024

Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis

in Red Cells, Iron and Erythropoiesis

Laura Pelagatti
Giulia Pozzi
Samuele Cortellazzi
Cristina Mancini
Eugenia Martella
Luca Pagliaro
Mariateresa Giaimo
Giovanni Roti
Marco Vitale
Cecilia Carubbi

Frontiers in Hematology

doi 10.3389/frhem.2024.1356561

1,280 views

Brief Research Report

Published on 09 Apr 2024

Evaluating the effectiveness of COVID-19 vaccines in adults with sickle cell disease during the Omicron period of COVID-19 pandemic

in Red Cells, Iron and Erythropoiesis

Kim Abbegail Tan Aldecoa
Chef Stan L. Macaraeg
Camelia Arsene
Geetha Krishnamoorthy
Tiffany Chng
Garrett Cherry
Nabila Chowdhury
Ryan Clark
Dana Deeb
Lisa Deptula

Frontiers in Hematology

doi 10.3389/frhem.2024.1365268

758 views

Brief Research Report

Published on 04 Apr 2024

Constructing a novel clinical indicator model to predict the occurrence of thalassemia in pregnancy through machine learning algorithm

in Red Cells, Iron and Erythropoiesis

Yaoshui Long
Wenxue Bai

Frontiers in Hematology

doi 10.3389/frhem.2024.1341225

870 views
1 citation

Clinical Trial

Published on 28 Mar 2024

Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study

in Blood Cancer

Ulrich Jaeger
Ingrid Simonitsch-Klupp
Patrick Klammer
Alexander Egle
Sonja Heibl
Peter Neumeister
Ella Willenbacher
Florian Erlsbacher
Julian Larcher-Senn
Philipp B. Staber

Frontiers in Hematology

doi 10.3389/frhem.2024.1331008

898 views

Review

Published on 28 Mar 2024

Blood pharming: exploring the progress and hurdles in producing in-vitro red blood cells for therapeutic applications

in Hematopoiesis and Stem Cells

Hammad Hassan
Sheerien Rajput

Frontiers in Hematology

doi 10.3389/frhem.2024.1373408

2,472 views

Review

Published on 26 Mar 2024

Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives

in Hematopoiesis and Stem Cells

Jessica Nunes
Dirk Loeffler

Frontiers in Hematology

doi 10.3389/frhem.2024.1373554

2,760 views
2 citations

Case Report

Published on 21 Mar 2024

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation

in Blood Cancer

Flavia Antonucci
Serena Marotta
Maria Celentano
Mariangela Pedata
Cira Riccardi
Cristina Luise
Angela Carobene
Simona Maria Muggianu
Assunta Viola
Mafalda Caputo

Frontiers in Hematology

doi 10.3389/frhem.2024.1345884

840 views

Opinion

Published on 18 Mar 2024

The impact of NETosis on hematological malignancies as a promising therapeutic target

in Blood Cancer

Duygu Aydemir

Frontiers in Hematology

doi 10.3389/frhem.2024.1377806

999 views
1 citation

Review

Published on 08 Mar 2024

Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East

in Immunobiology and Immunotherapy

Maria Dimou
Mohamed Abuzakouk
Mona Al Ahmad
Khalil Al Farsi
Ahmad Alhuraiji
Fayhan Al Roqi
Ahmed Alsaeed
Mohsen Alzahrani
Ali Bazarbachi
Honar Cherif

Frontiers in Hematology

doi 10.3389/frhem.2024.1347708

2,048 views
1 citation

Navigation group

Articles

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

Novel cryopreservation medium for enhanced stability of T cells at −80°C

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

Exploring extramedullary hematopoiesis: unraveling the hematopoietic microenvironments

Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis

AL amyloidosis: an overview on diagnosis, staging system, and treatment

Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma

Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis

Evaluating the effectiveness of COVID-19 vaccines in adults with sickle cell disease during the Omicron period of COVID-19 pandemic

Constructing a novel clinical indicator model to predict the occurrence of thalassemia in pregnancy through machine learning algorithm

Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study

Blood pharming: exploring the progress and hurdles in producing in-vitro red blood cells for therapeutic applications

Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation

The impact of NETosis on hematological malignancies as a promising therapeutic target

Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East